Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaseron Extension Study in RRMS
NCT00235989Phase 2Completed
- Sponsor
- Bayer
- Start
- Jun 2003
- Primary completion
- Jan 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1b in relapsing-remitting multiple sclerosis (RRMS), sponsored by Bayer. Started Jun 2003; status: completed.
02
Drugs
interferon beta-1b
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00235989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235989.